MiR-375 regulates the canonical Wnt pathway through FZD8 silencing in arthritis synovial fibroblasts

Immunology Letters

Volumn 164, Issue 1, 2015, Pages 1-10

  Miao, Cheng gui ^a,b   Shi, Wei jing ^a   Xiong, You yi ^a   Yu, Hao ^a   Zhang, Xiao lin ^a   Qin, Mei song ^a   Du, Chuan lai ^a   Song, Tong wen ^c   Li, Jun ^b  

^a ANHUI SCIENCE AND TECHNOLOGY UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c BENGBU MEDICAL COLLEGE   (China)

Author keywords

Adjuvant induced arthritis; Canonical wnt signaling; Frizzled 8; MiR 375; Rheumatoid arthritis

Indexed keywords

BETA CATENIN; FIBRONECTIN; FRIZZLED 8; FRIZZLED PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA 375; STROMELYSIN; UNCLASSIFIED DRUG; WNT PROTEIN; CELL SURFACE RECEPTOR; FZD8 PROTEIN, RAT; MICRORNA; MIRN375 MICRORNA, RAT;

3' UNTRANSLATED REGION; ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; DOWN REGULATION; FIBROBLAST; GENE OVEREXPRESSION; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; REPORTER GENE; RNA INTERFERENCE; UPREGULATION; ANIMAL; DISEASE MODEL; EXPERIMENTAL ARTHRITIS; GENE EXPRESSION; GENE SILENCING; GENETICS; MALE; METABOLISM; RHEUMATOID ARTHRITIS; SYNOVIUM; WNT SIGNALING PATHWAY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BETA CATENIN; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; MALE; MICRORNAS; RATS; RECEPTORS, CELL SURFACE; RNA INTERFERENCE; SYNOVIAL MEMBRANE; WNT SIGNALING PATHWAY;

EID: 84922460253     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2015.01.003     Document Type: Article

References (41)

1. Rosado-de-Castro P.H., Lopes de Souza S.A., Alexandre D., Barbosa da Fonseca L.M., Gutfilen B. Rheumatoid arthritis: nuclear medicine state-of-the-art imaging. World J Orthop 2014, 5(3):312-318.
2. Kim S. Interleukin-32 in inflammatory autoimmune diseases. Immune Netw 2014, 14(3):123-127.
3. García-Gómez C., Bianchi M., de la Fuente D., Badimon L., Padró T., Corbella E., et al. Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: a qualitative relationship?. World J Orthop 2014, 5(3):304-311.
4. Mallory G.W., Halasz S.R., Clarke M.J. Advances in the treatment of cervical rheumatoid: less surgery and less morbidity. World J Orthop 2014, 5(3):292-303.
5. Li H., Wan A. Apoptosis of rheumatoid arthritis fibroblast-like synoviocytes: possible roles of nitric oxide and the thioredoxin 1. Mediators Inflamm 2013, 2013:953462.
6. Bottini N., Firestein G.S. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol 2013, 9(1):24-33.
7. Solomon D.H., Bitton A., Katz J.N., Radner H., Brown E.M., Fraenkel L. Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?. Arthritis Rheumatol 2014, 66(4):775-782.
8. Miao C.G., Yang Y.Y., He X., Li X.F., Huang C., Huang Y., et al. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cell Signal 2013, 25(10):2069-2078.
9. Sen M., Reifert J., Lauterbach K., Wolf V., Rubin J.S., Corr M., et al. Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum 2002, 46(11):2867-2877.
10. Lien W.H., Fuchs E. Wnt some lose some: transcriptional governance of stem cells by Wnt/β-catenin signaling. Genes Dev 2014, 28(14):1517-1532.
11. Miao C.G., Yang Y.Y., He X., Huang C., Huang Y., Zhang L., et al. Wnt signaling in liver fibrosis: progress, challenges and potential directions. Biochimie 2013, 95(12):2326-2335.
12. Sen M., Chamorro M., Reifert J., Corr M., Carson D.A. Blockade of Wnt-5A/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum 2001, 44(4):772-781.
13. Nakamura Y., Nawata M., Wakitani S. Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am J Pathol 2005, 167(1):97-105.
14. Cheon H., Boyle D.L., Firestein G.S. Wnt1 inducible signaling pathway protein-3 regulation and microsatellite structure in arthritis. J Rheumatol 2004, 31(11):2106-2114.
15. Miao C.G., Yang Y.Y., He X., Xu T., Huang C., Huang Y., et al. New advances of microRNAs in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery. Cell Signal 2013, 25(5):1118-1125.
16. Bottini N., Firestein G.S. Epigenetics in rheumatoid arthritis: a primer for rheumatologists. Curr Rheumatol Rep 2013, 15(11):372.
17. Nakasa T., Nagata Y., Yamasaki K., Ochi M. A mini-review: microRNA in arthritis. Physiol Genomics 2011, 43(10):566-570.
18. Niimoto T., Nakasa T., Ishikawa M., Okuhara A., Izumi B., Deie M., et al. MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet Disord 2010, 11:209.
19. Huang Y., Crawford M., Higuita-Castro N., Nana-Sinkam P., Ghadiali S.N. miR-146a regulates mechanotransduction and pressure-induced inflammation in small airway epithelium. FASEB J 2012, 26(8):3351-3364.
20. Martinez-Nunez R.T., Louafi F., Friedmann P.S., Sanchez-Elsner T. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem 2009, 284(24):16334-16342.
21. Long L., Yu P., Liu Y., Wang S., Li R., Shi J., et al. Upregulated microRNA-155 expression in peripheral blood mononuclear cells and fibroblast-like synoviocytes in rheumatoid arthritis. Clin Dev Immunol 2013, 2013:296139.
22. Shibuya H., Nakasa T., Adachi N., Nagata Y., Ishikawa M., Deie M., et al. Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation. Mod Rheumatol 2013, 23(4):674-685.
23. Lu M.C., Yu C.L., Chen H.C., Yu H.C., Huang H.B., Lai N.S. Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production. Clin Exp Immunol 2014, 177(3):641-651.
24. Pandis I., Ospelt C., Karagianni N., Denis M.C., Reczko M., Camps C., et al. Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model. Ann Rheum Dis 2012, 71(10):1716-1723.
25. Masi A.T., Rehman A.A., Cutolo M., Aldag J.C. Do women with premenopausal-onset rheumatoid arthritis have relative insufficiency or imbalance of adrenocortical steroids?. Ann N Y Acad Sci 2014, 1317:7-16.
26. Ma X., Xu S. TNF inhibitor therapy for rheumatoid arthritis. Biomed Rep 2013, 1(2):177-184.
27. Nanki T., Nagasaka K., Hayashida K., Saita Y., Miyasaka N. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol 2001, 167(9):5381-5385.
28. Kim K.W., Cho M.L., Kim H.R., Ju J.H., Park M.K., Oh H.J., et al. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum 2007, 56(4):1076-1086.
29. Kraan M.C., Haringman J.J., Weedon H., Barg E.C., Smith M.D., Ahern M.J., et al. T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2004, 63(5):483-488.
30. Tian J., Chen J.W., Gao J.S., Li L., Xie X. Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway. Rheumatol Int 2013, 33(7):1829-1835.
31. Bradfield P.F., Amft N., Vernon-Wilson E., Exley A.E., Parsonage G., Rainger G.E., et al. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue. Arthritis Rheum 2003, 48(9):2472-2482.
32. Saravanan S., Islam V.I., Thirugnanasambantham K., Pazhanivel N., Raghuraman N., Paulraj M.G., et al. Swertiamarin ameliorates inflammation and osteoclastogenesis intermediates in IL-1β induced rat fibroblast-like synoviocytes. Inflamm Res 2014, 63(6):451-462.
33. Choi Y.S., Kang E.H., Lee E.Y., Gong H.S., Kang H.S., Shin K., et al. Joint-protective effects of compound K, a major ginsenoside metabolite, in rheumatoid arthritis: in vitro evidence. Rheumatol Int 2013, 33(8):1981-1990.
34. Rabelo Fde S., da Mota L.M., Lima R.A., Lima F.A., Barra G.B., de Carvalho J.F., et al. The Wnt signaling pathway and rheumatoid arthritis. Autoimmun Rev 2010, 9(4):207-210.
35. Sen M., Lauterbach K., El-Gabalawy H., Firestein G.S., Corr M., Carson D.A. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci USA 2000, 97(6):2791-2796.
36. Bai Y., Lu W., Han N., Bian H., Zhu M. Functions of miR126 and innate immune response. Yi Chuan 2014, 36(7):631-636.
37. Galicia J.C., Naqvi A.R., Ko C.C., Nares S., Khan A.A. MiRNA-181a regulates Toll-like receptor agonist-induced inflammatory response in human fibroblasts. Genes Immunol 2014, 15(5):333-337.
38. Yan S., Yim L.Y., Lu L., Lau C.S., Chan V.S. MicroRNA regulation in systemic Lupus Erythematosus pathogenesis. Immune Netw 2014, 14(3):138-148.
39. Jiang C., Zhu W., Xu J., Wang B., Hou W., Zhang R., et al. MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats. Arthritis Res Ther 2014, 16(1):R9.
40. Lin J., Huo R., Xiao L., Zhu X., Xie J., Sun S., et al. A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol 2014, 66(1):49-59.
41. Li X., Tian F., Wang F. Rheumatoid arthritis-associated microRNA-155 targets SOCS1 and upregulates TNF-α and IL-1β in PBMCs. Int J Mol Sci 2013, 14(12):23910-23921.